Startseite The DATAC study: a new growth database. Description of the epidemiology, diagnosis and therapeutic attitude in a group of Spanish children with short stature
Artikel
Lizenziert
Nicht lizenziert Erfordert eine Authentifizierung

The DATAC study: a new growth database. Description of the epidemiology, diagnosis and therapeutic attitude in a group of Spanish children with short stature

  • María Dolores Rodríguez Arnao EMAIL logo , Amparo Rodríguez Sánchez , César García-Rey , Francisco Javier Arroyo Díez , Ramón Cañete Estrada , Beatriz García Cuartero , María Alija Merillas und Juan P. López-Siguero
Veröffentlicht/Copyright: 11. September 2014

Abstract

Background: Recombinant human growth hormone (rhGH) availability has allowed the treatment of a greater number of growth disorders. It is important to get an insight into the clinical characteristics of the paediatric population before rhGH treatment.

Methods: An observational, retrospective and multicentre study was conducted to evaluate the patients’ baseline characteristics prior to rhGH therapy.

Results: A total of 1404 patients (53.8% males) aged 0.5–17.3 years were included. Clinical conditions were as follows: GH deficiency (GHD), 66.0%; small for gestational age (SGA), 29.7%; and Turner syndrome (TS), 4.3%. Male gender was predominant in most growth disorders; age at diagnosis was higher in GHD patients; therapy with rhGH started at lower chronological age in SGA and TS groups.

Conclusion: The baseline characteristics of the population to be treated with rhGH were similar to those reported in other growth databases. Delayed age at treatment initiation should increase the awareness of these disorders among general paediatricians and entice them to refer children suspected of having these disorders to a specialist.


Corresponding author: María Dolores Rodríguez Arnao, MD., Paediatric Endocrinology Unit, University Hospital Gregorio Marañón C/ Doctor Esquerdo, 46., 28007 Madrid, Spain, Phone: +34-91529 0118, E-mail:
aMembers of the DATAC study group are listed in alphabetical order in the Acknowledgements section.

Acknowledgments

We would like to thank the following members of the DATAC group: Alija Merillas M (H.G.U. de Guadalajara, Guadalajara); Aragonés Gallego A (H. Virgen de la Salud, Toledo); Argente Oliver J (H.I.U. Niño Jesús, Madrid); Arroyo Díez FJ (H. San Pedro de Alcántara, Cáceres); Bermúdez de la Vega JA (H.U. Virgen de la Macarena, Sevilla); Bernal Cerrato S (H.U. Virgen de la Macarena, Sevilla); Bezanilla López C (Fundación H. de Alcorcón, Madrid); Bonet Alcaina M (H. del Mar, Barcelona); Borrás Pérez MV (H. G. de Granollers, Barcelona); Bosch Muñoz J (H. Arnau de Vilanova, Lérida); Cabrinety Pérez N (H. Sagrado Corazón, Barcelona); Cañete Estrada R (H.U. Reina Sofía. Córdoba); Caro Cruz E (H.G.E. Ciudad de Jaén, Jaén); Carranza Ferrer M (H. Nostra Senyora de Meritxell, Andorra); Casas Rivero J (H. Ruber Internacional, Madrid); Corripio Collado R, Nosás Cuervo R (H. Parc Taulí Sabadell, Barcelona); Domínguez García A (H. Materno Infantil, Las Palmas); Feliu Rovira A (H.I. San Joan de Deu, Barcelona); Fernández García JM (H. Clínico San Cecilio, Granada); Fernández López JI (H. Nuestra Señora de Valme, Sevilla); Fernández Tena I (Clínica Clideba, Badajoz); Ferrer Lozano M (H.G. San Jorge. Zaragoza); Fuentes Castelló MA (H.G.U. de Elche, Alicante); Garagorri Otero JM (H.C.U. Lozano Blesa, Zaragoza); García Cuartero B (H.U. Severo Ochoa, Madrid); García-Rey C (Medical Department, Merck SL, Madrid); Gavilán Villarejo I (H. U. Puerta del Mar, Cádiz); Gentil González FJ (H.U. Virgen de la Macarena, Sevilla); González Vergaz A (H.U. Severo Ochoa, Madrid); Gutiérrez Díez MP (H.U. de Getafe, Madrid); Hernando Mayor JC (H. del Río Ortega, Valladolid); Jiménez Fernández ER (H. Infanta Elena, Huelva); Jurado Muñoz MC (Clínica Esperanza de Triana, Sevilla); Lalaguna Mallada P (H. de Barbastro, Huesca); Lechuga Campoy JL (H. U. Puerta del Mar, Cádiz); López Capapé M (H. La Moraleja, Madrid); López Siguero JP (H. U. Materno Infantil Carlos Haya, Málaga); Martín Hernández T (H.U. Virgen de la Macarena, Sevilla); Martínez Aedo MJ (H. U. Materno Infantil Carlos Haya, Málaga); Macías López FJ (H. de Jerez, Cádiz); Moreno Macián F (H.U. La Fe, Valencia); Núñez Estévez M (H. Materno Infantil Infanta Cristina, Badajoz); Oliver Iguácel A (H.U. La Paz, Madrid); Ortega Gamboa D (Medical Department, Merck SL, Madrid); Quinteiro González S (H. Materno Infantil, Las Palmas); Ramírez Fernández J (H.U. Príncipe de Asturias, Alcalá de Henares); Rial Rodríguez JM (C. H. Nuestra Señora de la Candelaria, Tenerife); Rodríguez Arnao MD (H.G.U. Gregorio Marañón, Madrid. Study Coordinator); Rodríguez Rodríguez I (C. H. Nuestra Señora de la Candelaria, Tenerife); Rodríguez Sánchez A (H.G.U. Gregorio Marañón, Madrid. Study Coordinator); Ruíz Cano R (C.H.U. de Albacete, Albacete); Sala Sánchez G (H. Virgen de los Lirios, Alicante); Sánchez Huelva H (H. Infanta Elena, Huelva); Sendón Pérez A (H.U. Virgen de la Macarena, Sevilla); Yturriaga Matarranz R (H.U. Ramón y Cajal, Madrid); Zapico Álvarez-Cascos M (H.G.U. de Alicante, Alicante).

We also want to show our gratitude to Patricia Santagueda for her help with the statistical analysis and to Almudena Pardo-Mateos for editing the original manuscript.

Conflict of interest statement

Authors’ conflict of interest disclosure: DATAC has been sponsored by Merck Serono.

References

1. Cook DM, Rose SR. A review of guidelines for use of growth hormone in pediatric and transition patients. Pituitary 2012;15:301–10.10.1007/s11102-011-0372-6Suche in Google Scholar

2. Oostdijk W, Grote FK, de Muinck Keizer-Schrama SM, Wit JM. Diagnostic approach in children with short stature. Horm Res 2009;72:202–17.10.1159/000236082Suche in Google Scholar

3. Allen DB, Cutler L. Short stature in childhood. Challenges and choices. N Engl J Med 2013;368:1220–8.10.1056/NEJMcp1213178Suche in Google Scholar

4. Franklin SL, Geffner ME. Growth hormone: the expansion of available products and indications. Pediatr Clin North Am 2011;58:1141–65.10.1016/j.pcl.2011.07.006Suche in Google Scholar

5. Pozo J, Martos-Moreno GA, Barrios V, Argente J. The IGF system in childhood: physiology and clinical implications. J Endocrinol Invest 2005;28:38–42.Suche in Google Scholar

6. Wilson TA, Rose SR, Cohen P, Rogol AD, Backeljauw P, et al. Update of guidelines for the use of growth hormone in children: the Lawson Wilkins Pediatric Endocrinology Society Drug and Therapeutics Committee. J Pediatr 2003;143:415–21.10.1067/S0022-3476(03)00246-4Suche in Google Scholar

7. Boguszewski MC, Mericq V, Bergada I, Damiani D, Belgorosky A, et al. Latin American consensus: children born small for gestational age. BMC Pediatr 2011;11:66.10.1186/1471-2431-11-66Suche in Google Scholar PubMed PubMed Central

8. Clayton PE, Cianfarani S, Czernichow P, Johannsson G, Rapaport R, et al. Management of the child born small for gestational age through to adulthood: a consensus statement of the international societies of pediatric endocrinology and the growth hormone research society. J Clin Endocrinol Metab 2007;92:804–10.10.1210/jc.2006-2017Suche in Google Scholar PubMed

9. Gharib H, Cook DM, Saenger PH, Bengtsson BA, Feld S, et al. American Association of Clinical Endocrinologists medical guidelines for clinical practice for growth hormone use in adults and children – 2003 update. Endocr Pract 2003;9:64–76.10.4158/EP.9.1.64Suche in Google Scholar PubMed

10. Ranke M. KIGS: 20 years. Horm Res 2007;68:40–4.10.1159/000110473Suche in Google Scholar PubMed

11. Carrascosa A, Audi L, Fernandez–Cancio M, Yeste D, Gussinye M, et al. Growth hormone secretory status evaluated by growth hormone peak after two pharmacological growth hormone release stimuli did not significantly influence the two-year catch-up growth induced by growth hormone therapy in 318 prepubertal short children with idiopathic growth retardation. Horm Res Paediatr 2011;75:106–14.10.1159/000318782Suche in Google Scholar PubMed

12. Sobradillo B, Aguirre A, Aresti. U, Bilbao A, Fernández-Ramos C, et al. Curvas y tablas de crecimiento. Estudios longitudinal y transversal. Bilbao: Fundación Faustino Orbegozo 2004. Available at: http://www.slideshare.net/Karlatareas/tablas-orbegozo1.Suche in Google Scholar

13. Greulich WW, Pyle SI. Radiographic atlas of skeletal development of the hand and wrist, 2nd ed. Standford, CA, USA: Standford University Press, 1959.10.1097/00000441-195909000-00030Suche in Google Scholar

14. Bayley N, Pinneau SR. Tables for predicting adult height from skeletal age: revised for use with the Greulich-Pyle hand standards. J Pediatr 1952;40:423–41.10.1016/S0022-3476(52)80205-7Suche in Google Scholar

15. Flor-Cisneros A, Roemmich JN, Rogol AD, Baron J. Bone age and onset of puberty in normal boys. Mol Cell Endocrinol 2006;254–255:202–6.10.1016/j.mce.2006.04.008Suche in Google Scholar PubMed PubMed Central

16. Argente J, Barrios V, Pozo J, Munoz MT, Hervas F, et al. Normative data for insulin-like growth factors (IGFs), IGF-binding proteins, and growth hormone-binding protein in a healthy Spanish pediatric population: Age- and sex-related changes. J Clin Endocrinol Metab 1993;77:1522–8.Suche in Google Scholar

17. Elmlinger MW, Kuhnel W, Weber MM, Ranke MB. Reference ranges for two automated chemiluminescent assays for serum insulin-like growth factor I (IGF-I) and IGF-binding protein 3 (IGFbp-3). Clin Chem Lab Med 2004;42:654–64.10.1515/CCLM.2004.112Suche in Google Scholar PubMed

18. Reiter EO, Blethen SL, Baptista J, Price L. Early initiation of growth hormone treatment allows age-appropriate estrogen use in Turner’s syndrome. J Clin Endocrinol Metab 2001;86:1936–41.10.1210/jc.86.5.1936Suche in Google Scholar

19. van Pareren YK, de Muinck Keizer-Schrama SM, Stijnen T, Sas TC, Jansen M, et al. Final height in girls with Turner syndrome after long-term growth hormone treatment in three dosages and low dose estrogens. J Clin Endocrinol Metab 2003;88:1119–25.10.1210/jc.2002-021171Suche in Google Scholar PubMed

20. Gandrud LM, Wilson DM. Is growth hormone stimulation testing in children still appropriate? Growth Horm IGF Res 2004;14:185–94.10.1016/j.ghir.2003.11.003Suche in Google Scholar PubMed

21. Hughes IP, Harris M, Choong CS, Ambler G, Cutfield W, et al. Growth hormone regimens in Australia: analysis of the first 3 years of treatment for idiopathic growth hormone deficiency and idiopathic short stature. Clin Endocrinol (Oxf) 2012;77:62–71.10.1111/j.1365-2265.2011.04230.xSuche in Google Scholar PubMed

22. Audi L, Llopis MA, Granada ML, Hermoso F, del Valle J, et al. Low sensitivity of IGF-1, IGFBP-3 and urinary GH in the diagnosis of growth hormone insufficiency in slowly-growing short-statured boys. Grupo Español de Estudio de la Talla Baja. Med Clin (Barc) 2001;116:6–11.Suche in Google Scholar

23. Savage MO, Burren CP, Rosenfeld RG. The continuum of growth hormone-IGF-1 axis defects causing short stature: diagnostic and therapeutic challenges. Clin Endocrinol (Oxf) 2010;72:721–8.10.1111/j.1365-2265.2009.03775.xSuche in Google Scholar PubMed

24. Hughes IP, Choong CS, Cotterill A, Harris M, Davies PS. Gender bias in children receiving growth hormone treatment. J Clin Endocrinol Metab 2010;95: 1191–8.10.1210/jc.2009-1563Suche in Google Scholar PubMed

25. Wilson TA, Rose SR, Cohen P, Rogol AD, Backeljauw P, et al. Update of guidelines for the use of growth hormone in children: The Lawson Wilkins Pediatric Endocrinology Society Drug and Therapeutics Committee. J Pediatr 2003;143:415–21.10.1067/S0022-3476(03)00246-4Suche in Google Scholar

Received: 2013-10-8
Accepted: 2014-7-3
Published Online: 2014-9-11
Published in Print: 2014-11-1

©2014 by De Gruyter

Artikel in diesem Heft

  1. Frontmatter
  2. Highlight: Cushing syndrome
  3. Fundamental principles of clinical and biochemical evaluation underlie the diagnosis and therapy of Cushing’s syndrome
  4. Cushing syndrome secondary to CRH-producing Wilms tumor in a 6 year old
  5. Cushing’s disease presenting as cholestatic hepatitis
  6. How early can one diagnose Cushing’s disease? An early diagnosis in a case of prepubertal Cushing’s disease
  7. Review article
  8. Subclinical hypothyroidism in childhood and adolescense
  9. Original articles
  10. Energy substrate metabolism in pyruvate dehydrogenase complex deficiency
  11. Chromosome 6q24 transient neonatal diabetes mellitus and protein sensitive hyperinsulinaemic hypoglycaemia
  12. Measures of pituitary gland and stalk: from neonate to adolescence
  13. Are preterm newborns who have relative hyperthyrotropinemia at increased risk of brain damage?
  14. Pseudohypoparathyroidism vs. tricho-rhino-phalangeal syndrome: patient reclassification
  15. Association of serum 25-hydroxyvitamin D with race/ethnicity and constitutive skin color in urban schoolchildren
  16. A nonsense thyrotropin receptor gene mutation (R609X) is associated with congenital hypothyroidism and heart defects
  17. Acanthosis nigricans, vitamin D, and insulin resistance in obese children and adolescents
  18. Clinical characteristics and chromosome 11p15 imprinting analysis of Silver-Russell syndrome – a Chinese experience
  19. Change in reference body mass index percentiles and deviation in overweight and obesity over 3 years in Turkish children and adolescents
  20. Long-term outcomes of pediatric Graves’ disease
  21. Accessibility of the reference center as a protective factor against ketoacidosis at the onset of diabetes in children
  22. Vitamin D, parathormone, and insulin resistance in children born large for gestational age
  23. Prevalence of vitamin D deficiency in apparently healthy children in north India
  24. Prevalence of autoantibodies in type 1 diabetes patients and its association with the clinical presentation – UAE Eastern Region experience
  25. Clinical and molecular studies related to bone metabolism in patients with congenital adrenal hyperplasia
  26. Islet neogenesis-associated protein-related pentadecapeptide improves the function of allograft after islets transplantation
  27. Anti-Mullerian hormone may be a useful adjunct in the diagnosis of polycystic ovary syndrome in nonobese adolescents
  28. Early infant feeding practice and childhood obesity: the relation of breast-feeding and timing of solid food introduction with childhood obesity
  29. Late onset X-linked adrenal hypoplasia congenita with hypogonadotropic hypgonadism due to a novel 4-bp deletion in exon 2 of NR0B1
  30. The correlation between GnRH stimulation testing and obstetric ultrasonographic parameters in precocious puberty
  31. The DATAC study: a new growth database. Description of the epidemiology, diagnosis and therapeutic attitude in a group of Spanish children with short stature
  32. Concentrations of tumour necrosis factor-α and its soluble receptors in the serum of teenagers with atherosclerosis risk factors: obesity or obesity combined with hypertension
  33. Are HDL levels lower in children with type 1 diabetes and concurrent celiac disease compared with children with type 1 diabetes only?
  34. Patient reports
  35. Hereditary vitamin D rickets: a case series in a family
  36. Two heterozygous mutations of the AMH gene in a Japanese patient with persistent Müllerian duct syndrome
  37. Two case reports of severe pediatric hyperosmolar hyperglycemia and diabetic ketoacidosis accompanied with rhabdomyolysis and acute renal failure
  38. Acquired hypothyroidism due to iodine deficiency in an American child
  39. Continuous subcutaneous IGF-1 therapy via insulin pump in a patient with Donohue syndrome
  40. Amylase/creatinine clearance ratio in diabetic ketoacidosis: a case report
  41. Worsening hypertriglyceridemia with oral contraceptive pills in an adolescent with HIV-associated lipodystrophy: a case report and review of the literature
  42. Congenital hyperinsulinism in a newborn with a novel homozygous mutation (p.Q392H) in the ABCC8 gene
  43. Short communications
  44. Polyglandular autoimmune syndrome type I – a novel AIRE mutation in a North American patient
  45. Post-hemorrhagic hydrocephalus and diabetes insipidus in preterm infants
  46. Two novel mutations in acid α-glucosidase gene in two patients with Pompe disease
  47. Letter to the Editor
  48. And what about septin 9 (SEPT9) as a binding partner of survivin in heart regeneration?
Heruntergeladen am 3.12.2025 von https://www.degruyterbrill.com/document/doi/10.1515/jpem-2013-0394/html?lang=de
Button zum nach oben scrollen